全文获取类型
收费全文 | 1278426篇 |
免费 | 98042篇 |
国内免费 | 1989篇 |
专业分类
耳鼻咽喉 | 18423篇 |
儿科学 | 44349篇 |
妇产科学 | 35008篇 |
基础医学 | 182162篇 |
口腔科学 | 33585篇 |
临床医学 | 111242篇 |
内科学 | 258205篇 |
皮肤病学 | 28020篇 |
神经病学 | 100360篇 |
特种医学 | 51198篇 |
外国民族医学 | 660篇 |
外科学 | 196374篇 |
综合类 | 27048篇 |
现状与发展 | 1篇 |
一般理论 | 377篇 |
预防医学 | 95713篇 |
眼科学 | 27912篇 |
药学 | 94761篇 |
2篇 | |
中国医学 | 2422篇 |
肿瘤学 | 70635篇 |
出版年
2018年 | 13131篇 |
2017年 | 9962篇 |
2016年 | 10896篇 |
2015年 | 12369篇 |
2014年 | 17162篇 |
2013年 | 26208篇 |
2012年 | 36016篇 |
2011年 | 38051篇 |
2010年 | 22798篇 |
2009年 | 21806篇 |
2008年 | 36633篇 |
2007年 | 39243篇 |
2006年 | 39498篇 |
2005年 | 38437篇 |
2004年 | 37589篇 |
2003年 | 36445篇 |
2002年 | 35793篇 |
2001年 | 63987篇 |
2000年 | 66494篇 |
1999年 | 56407篇 |
1998年 | 15128篇 |
1997年 | 13753篇 |
1996年 | 14195篇 |
1995年 | 13452篇 |
1994年 | 12765篇 |
1993年 | 11790篇 |
1992年 | 44554篇 |
1991年 | 43464篇 |
1990年 | 42216篇 |
1989年 | 40111篇 |
1988年 | 36894篇 |
1987年 | 36234篇 |
1986年 | 33618篇 |
1985年 | 32278篇 |
1984年 | 24136篇 |
1983年 | 20268篇 |
1982年 | 11723篇 |
1981年 | 10691篇 |
1980年 | 9515篇 |
1979年 | 21341篇 |
1978年 | 14821篇 |
1977年 | 12532篇 |
1976年 | 11693篇 |
1975年 | 12623篇 |
1974年 | 14661篇 |
1973年 | 14117篇 |
1972年 | 12944篇 |
1971年 | 11729篇 |
1970年 | 11050篇 |
1969年 | 10024篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
贺晓新 《结核与肺部疾病杂志》2006,1(3):153-156
科学研究的目标是创造和传播知识。这得通过对系统收集以及报告信息的批判性分析来完成。批判性分析始于一个简单的步骤,即在运用复杂统计学分析方法进行比较之前对所收集的数据进行深入检查。根据所收集的数据类型按照标准化方式进行统计学分析。在为解决研究问题而需采用合理、标准化步骤进行比较时,新知识就产生了,同时要避免错误的结论。在对数据进行仔细检查和分析之后,为了保证结论的正确性,再对数据进行一次批判性评论是非常重要的补充步骤。在科学文献中发表研究成果过程中涉及的同行评价对于传播新知识并保证其质量方面是一个非常重要的步骤。如果没有将研究成果发表供同行参考,这项研究就不算完整。 相似文献
54.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
55.
56.
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctive therapy, were observed for 1 year in 202 adult patients, aged 17-83 years, with newly diagnosed or refractory partial epilepsy in clinical practice in Italy. At first observation, the seizure free rate was 72.2% in newly diagnosed patients given monotherapy, 40% in patients in whom oxcarbazepine replaced another monotherapy and 10.3% in patients given oxcarbazepine as adjunctive therapy. At least 50% reduction in seizure frequency was achieved in 90.7, 72 and 57%, respectively. Efficacy increased with the duration of treatment (p < 0.0001). In the 160 completers the seizure free rate was 61.3% with monotherapy and 28% with adjunctive therapy. 16.3% of patients reported adverse effects, mainly sedation and sleepiness; 5% discontinued oxcarbazepine because of adverse events. OXC is an effective and well-tolerated antiepileptic agent for the long-term treatment of partial epilepsy in adults. 相似文献
57.
58.
59.
K P Sylvester S R Desai A U Wells D M Hansell M Awogbade S L Thein A Greenough 《The European respiratory journal》2006,28(4):832-838
The aim of this study was to determine whether patients with sickle cell disease (SCD) in steady state had pulmonary abnormalities seen on high-resolution computed tomography (HRCT) and whether any abnormalities correlated with contemporaneously diagnosed lung function abnormalities. A subsidiary question was whether the results of a noninvasive measure of haemolysis (end-tidal carbon monoxide (ETCO) levels) correlated with pulmonary function abnormalities. Thirty three patients with SCD, median (range) age 36 yrs (17-67 yrs) were examined. The degree of lobar volume loss and ground-glass opacification and prominence of central vessels on HRCT were quantitatively assessed. Pulmonary function was assessed by measurements of lung volumes, spirometry, gas transfer and oxygen saturation. ETCO levels were measured using an end-tidal CO monitor. Forced expiratory volume in one second (FEV1), forced vital capacity and total lung capacity significantly correlated with HRCT findings, particularly lobar volume loss. ETCO levels significantly negatively correlated with FEV1, vital capacity measured using a plethysmograph, specific airway conductance and arterial oxygen saturation measured by pulse oxymetry. In conclusion, the present results suggest that high-resolution computed tomography noninvasive assessment of haemolysis might be useful to identify sickle cell disease patients with respiratory function impairment. 相似文献
60.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献